-
公开(公告)号：EP2148655B1
公开(公告)日：2013-02-27
申请号：EP08737878.2
申请日：2008-04-16
申请人： Wockhardt Limited , Ujjainkar, Amol , Balla Pattabhi, Srinivas , Khan, Abdul Rehman , Murali, Narayanan , Jain, Girish Kumar
发明人： UJJAINKAR, Amol , BALLA PATTABHI, Srinivas , KHAN, Abdul Rehman , MURALI, Narayanan , JAIN, Girish Kumar
CPC分类号： A61K31/4365 , A61K9/1652 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/2077 , A61K9/284 , A61K9/2866
-
公开(公告)号：EP2148655A2
公开(公告)日：2010-02-03
申请号：EP08737878.2
申请日：2008-04-16
申请人： Wockhardt Research Centre , Ujjainkar, Amol , Balla Pattabhi, Srinivas , Khan, Abdul Rehman , Murali, Narayanan , Jain, Girish Kumar
发明人： UJJAINKAR, Amol , BALLA PATTABHI, Srinivas , KHAN, Abdul Rehman , MURALI, Narayanan , JAIN, Girish Kumar
CPC分类号： A61K31/4365 , A61K9/1652 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/2077 , A61K9/284 , A61K9/2866
摘要： The invention relates to pharmaceutical compositions comprising clopidogrel or monobasic acid salts thereof in admixture with one or more hydrated excipients. The invention also relates to pharmaceutical compositions comprising clopidogrel or monobasic acid salts thereof which are free of any moisture scavenger. The invention also relates to processes for the preparation of such compositions.
-
公开(公告)号：EP2114374A2
公开(公告)日：2009-11-11
申请号：EP07866569.2
申请日：2007-12-20
申请人： Wockhardt Research Centre , Kalantri, Mahesh Rameshwar , Goswami, Sudhir , Murali, Narayanan , Jain, Girish Kumar
IPC分类号： A61K9/14
CPC分类号： A61K9/2095 , A61K9/2018 , A61K9/2054
摘要： The invention relates to pharmaceutical compositions comprising entacapone or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such compositions.
-
公开(公告)号：EP2142175A2
公开(公告)日：2010-01-13
申请号：EP08737625.7
申请日：2008-03-25
申请人： Wockhardt Research Centre , Gundu, Ramakant , Jain, Girish Kumar , Murali, Narayanan , Dabre, Rahul , Kodgule, Mandar
IPC分类号： A61K9/20 , A61K31/5575 , A61K31/196 , A61P15/00
CPC分类号： A61K31/5575 , A61K9/1676 , A61K9/2072 , A61K9/2077 , A61K9/2081 , A61K9/209 , A61K9/5026 , A61K9/5078 , A61K9/5084 , A61K31/196 , A61K2300/00
摘要： The present invention relates to pharmaceutical compositions of diclofenac or pharmaceutically acceptable salts thereof and misoprostol or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparations of such compositions.
-
公开(公告)号：EP2167048B1
公开(公告)日：2016-10-26
申请号：EP08737626.5
申请日：2008-03-25
IPC分类号： A61K31/557 , A61K9/20 , A61K9/24
CPC分类号： A61K9/2886 , A61K9/2072 , A61K9/209 , A61K31/196 , A61K31/40 , A61K31/4184 , A61K31/4418 , A61K31/4422 , A61K31/55 , A61K31/557 , A61K31/5575 , A61K45/06 , A61K2300/00
摘要： The present invention relates to novel tablet dosage forms and methods of preparing these forms, which can be used for different classes of pharmaceutical active ingredients posing stability issues in a single unit system. The dosage form includes a first layer, which includes a tablet of one or more active pharmaceutical ingredients, which is inlayed in the first layer along with other pharmaceutically acceptable excipients, and a second layer that includes one or more active pharmaceutical ingredients optionally with other pharmaceutically acceptable excipients.
-
公开(公告)号：EP2167048A2
公开(公告)日：2010-03-31
申请号：EP08737626.5
申请日：2008-03-25
IPC分类号： A61K9/20
CPC分类号： A61K9/2886 , A61K9/2072 , A61K9/209 , A61K31/196 , A61K31/40 , A61K31/4184 , A61K31/4418 , A61K31/4422 , A61K31/55 , A61K31/557 , A61K31/5575 , A61K45/06 , A61K2300/00
摘要： The present invention relates to novel tablet dosage forms and methods of preparing these forms, which can be used for different classes of pharmaceutical active ingredients posing stability issues in a single unit system. The dosage form includes a first layer, which includes a tablet of one or more active pharmaceutical ingredients, which is inlayed in the first layer along with other pharmaceutically acceptable excipients, and a second layer that includes one or more active pharmaceutical ingredients optionally with other pharmaceutically acceptable excipients.
-
公开(公告)号：EP2150242A2
公开(公告)日：2010-02-10
申请号：EP08737923.6
申请日：2008-04-19
申请人： Wockhardt Research Centre , Jain, Girish Kumar , Kandi, Chandrashekhar Shriram , Nande, Vishwanath
IPC分类号： A61K9/28 , A61K9/48 , A61K9/50 , A61K31/381
CPC分类号： A61K9/2886 , A61K9/2027 , A61K9/2059 , A61K9/2846 , A61K9/2866 , A61K9/4808 , A61K9/4891 , A61K9/5026 , A61K9/5047 , A61K9/5073 , A61K9/5078 , A61K31/381 , A61K47/585
摘要： The present invention relates to pharmaceutical compositions of duloxetine or pharmaceutically acceptable salts thereof, and processes for their preparation.
-
8.发明公开SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING FIXED DOSE COMBINATION OF METFORMIN AND SITAGLIPTIN OR SALTS THEREOF 审中-公开固体口服药物组合物FIXDOSIERUNGSKOMBINATION二甲双胍和西他列汀或其盐
公开(公告)号：EP3033075A1
公开(公告)日：2016-06-22
申请号：EP14721970.3
申请日：2014-03-21
申请人： Wockhardt Limited
IPC分类号： A61K9/20 , A61K9/24 , A61K9/50 , A61K31/155 , A61K31/4985
CPC分类号： A61K31/4985 , A61K9/209 , A61K9/2095 , A61K9/5084 , A61K31/155
摘要： The present invention provides solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to a multilayered coated pharmaceutical composition comprising at least two compartments of metformin or salts thereof exhibiting immediate and extended release and at least one compartment of sitagliptin and metformin or salts thereof exhibiting immediate release. The invention also includes process of preparing such compositions and method of use of such compositions for treating type II diabetes.
摘要翻译： 本发明提供了固体口服药物组合物包含二甲双胍和西他列汀或其盐的组合物。 特别地，本发明涉及多层涂覆的药物组合物包含二甲双胍的至少两个隔室或其盐参展立即和延长释放和西他列汀的至少一个隔室和二甲双胍或其盐参展立即释放。 因此，本发明包括制备寻求组合物和使用组合物的搜索的方法，用于治疗II型糖尿病的方法。
-
9.发明公开METHODS FOR TREATING CARDIOVASCULAR DISORDER 审中-公开VERFAHREN ZUR BEHANDLUNGKARDIOVASKULÄRERERKRANKUNGEN
公开(公告)号：EP2841061A1
公开(公告)日：2015-03-04
申请号：EP12809850.6
申请日：2012-11-01
申请人： Wockhardt Limited
IPC分类号： A61K31/135 , A61K31/4365 , A61K31/60 , A61P9/00
CPC分类号： A61K31/616 , A61K9/2009 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2068 , A61K31/138 , A61K31/4365 , A61K31/519 , A61K45/06 , A61K2300/00
摘要： The present invention relates to a once-a-day therapeutically synergistic pharmaceutical dosage form for treatment of cardiovascular disorders, wherein the dosage form comprises a fixed dose combination of metoprolol in extended release form and one or more antiplatelet agent along with one or more rate controlling excipients.
摘要翻译： 本发明涉及用于治疗心血管疾病的每日一次治疗协同药物剂型，其中该剂型包括延长释放形式的美托洛尔和一种或多种抗血小板药剂的固定剂量组合以及一种或多种速率控制 辅料。
-
10.发明公开PHARMACEUTICAL MICROPARTICULATE COMPOSITIONS OF POLYPEPTIDES 审中-公开MIKROPARTIKULÄREPHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUS POLYPEPTIDEN
公开(公告)号：EP2934562A1
公开(公告)日：2015-10-28
申请号：EP13729087.0
申请日：2013-05-02
申请人： Wockhardt Limited
发明人： KUMAR, Mukesh , JAIN, Girish Kumar
CPC分类号： A61K38/26 , A61K9/14 , A61K9/5031 , A61K38/2278 , A61K45/06
摘要： The present invention refers to pharmaceutical microparticulate compositions of biologically active polypeptides and methods of forming and using such compositions. More particularly, microparticle compositions for sustained release of biologically active polypeptides are provided. Compositions of biologically active polypeptides with desired release profile can be prepared without using any sugar. The microparticle compositions of this invention comprise a biocompatible polymer, a biologically active polypeptide, and optionally, pharmaceutical excipients other than sugar.
摘要翻译： 本发明涉及生物活性多肽的药物微粒组合物以及形成和使用这些组合物的方法。 更具体地，提供用于持续释放生物活性多肽的微粒组合物。 具有所需释放曲线的生物活性多肽的组合物可以在不使用任何糖的情况下制备。 本发明的微粒组合物包含生物相容的聚合物，生物活性多肽和任选的糖以外的药物赋形剂。
-
-
-
-
-
-
-
-
-
搜索结果
22 条记录 (耗时 0.016 秒)
